Pharmacokinetics of cefodizime following single doses of 0.5, 1.0, 2.0, and 3.0 grams administered intravenously to healthy volunteers

Antimicrobial Agents and Chemotherapy

Volumn 39, Issue 9, 1995, Pages 2037-2041

  Lenfant, B ^a   Namour, F ^a   Logeais, C ^a   Coussediere, D ^a   Rivault, O ^a   Bryskier, A ^a   Surjus, A ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CEFODIZIME;

ADULT; ANTIBACTERIAL ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; KIDNEY CLEARANCE; MALE; PLASMA CLEARANCE; PRIORITY JOURNAL; PROTEIN BINDING; RANDOMIZED CONTROLLED TRIAL;

EID: 0029151806     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.39.9.2037     Document Type: Article

References (0)